MedTrace Logo

Bilateral Transversus Abdominis Plane Block Versus Atracurium During Laparoscopic Gynecology Procedures.

NCT03701256 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-17

No results posted yet for this study

Summary

A monocentric, prospective, randomized controlled trial, including patients proposed for a laparoscopic gynecologic surgery comparing the muscular relaxing effect of a bilateral ultrasound-guided Transversus Abdominis Plane block to usual neuromuscular blockade agent (Atracurium)

Conditions

  • Neuromuscular Blockade
  • Regional Anesthesia

Interventions

PROCEDURE

Bilateral ultrasound guided TAP bloc

In the TAP group: Bilateral ultrasound guided TAP bloc for laparoscopic gynecologic surgery

DRUG

Neuromuscular blockade agent: Atracurium 01mg/kg per bolus

In the TRAC group: Neuromuscular blockade agent: Atracurium 01mg/kg per bolus for maintaining muscular relaxation and immobilization during laparoscopic gynecologic surgery

Sponsors & Collaborators

  • University Tunis El Manar

    lead OTHER

Principal Investigators

  • Hayen Maghrebi, Professor · Tunis Maternity Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2015-07-31
Completion
2015-10-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03701256 on ClinicalTrials.gov